Roble, Belko & Company »

Applied Therapeutics shares owned by Roble, Belko & Company

Quarter-by-quarter ownership of Applied Therapeutics (APLT) shares owned by Roble, Belko & Company from 13F filings

Historical chart of Roble, Belko & Company investment in Applied Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Applied Therapeutics held by Roble, Belko & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Applied Therapeutics by Roble, Belko & Company

Quarter filed Position value Share count Share price at filing
2025-09-30 $19k 31k 0.62
2025-06-30 $10k 31k 0.32

More positions owned by Roble, Belko & Company

Vanguard Index Fds Etf (VTI)
Vanguard Star Fds Etf (VXUS)
Vanguard Tax-managed Fds Etf (VEA)
Vanguard Bd Index Fds Etf (BND)
Vanguard Intl Equity Index Etf (VEU)
Vanguard Whitehall Fds Etf (VYM)
Select Sector Spdr Tr Etf (XLK)
Vanguard Index Fds Etf (VV)
Spdr S&p 500 Etf Tr Etf (SPY)
Spdr Ser Tr Portfoli S&p1500 Etf (SPTM)
Ishares Tr Rus 1000 Grw Etf (IWF)
Ishares Tr Blackrock Ultra Etf (ICSH)
Vanguard Index Fds Etf (VNQ)
Schwab Strategic Tr Etf (SCHB)
Vanguard Scottsdale Etf (VGIT)

View all positions for Roble, Belko & Company

Top funds holding Applied Therapeutics

T. Rowe Price Investment Management
Vestal Point Capital
Propel Bio Management
Knoll Capital Management
Vanguard Group
Simplify Asset Management
BlackRock
Pnc Financial Services
Pathstone Holdings
Marshall Wace
Adage Capital Partners GP
Rock Springs Capital Management
Franklin Resources
Millennium Management
UBS Group

View all funds holding Applied Therapeutics